Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 584

1.

Cerebrovascular disease burden in late-onset non-lesional focal epilepsy.

Abraira L, Gramegna LL, Quintana M, Santamarina E, Salas-Puig J, Sarria S, Rovira A, Toledo M.

Seizure. 2019 Feb 8;66:31-35. doi: 10.1016/j.seizure.2019.02.004. [Epub ahead of print]

PMID:
30776698
2.

Circulation of plasmids harboring resistance genes to quinolones and/or extended spectrum cephalosporins in multiple Salmonella enterica serotypes from swine in the United States.

Elnekave E, Hong SL, Lim S, Hayer SS, Boxrud D, Taylor AJ, Lappi V, Noyes N, Johnson TJ, Rovira A, Davies P, Perez A, Alvarez J.

Antimicrob Agents Chemother. 2019 Feb 11. pii: AAC.02602-18. doi: 10.1128/AAC.02602-18. [Epub ahead of print]

PMID:
30745386
3.

Human-Origin Influenza A(H3N2) Reassortant Viruses in Swine, Southeast Mexico.

Nelson MI, Souza C, Trovão NS, Diaz A, Mena I, Rovira A, Vincent AL, Torremorell M, Marthaler D, Culhane MR.

Emerg Infect Dis. 2019 Apr 17;25(4). doi: 10.3201/eid2504.180779. [Epub ahead of print]

4.

[Progressive multifocal leukoencephalopathy and non-specific immune dysfunction].

Campos-Fernandez D, Olive-Gadea M, Ballve-Martin A, Llaurado-Gayete A, Santamarina E, Rovira A, Rio J.

Rev Neurol. 2019 Feb 1;68(3):132-133. Spanish.

5.

Association between pathological and MRI findings in multiple sclerosis.

Filippi M, Brück W, Chard D, Fazekas F, Geurts JJG, Enzinger C, Hametner S, Kuhlmann T, Preziosa P, Rovira À, Schmierer K, Stadelmann C, Rocca MA; Attendees of the Correlation between Pathological and MRI findings in MS workshop.

Lancet Neurol. 2019 Feb;18(2):198-210. doi: 10.1016/S1474-4422(18)30451-4. Review.

PMID:
30663609
6.

Solid-Phase Approaches for Labeling Targeting Peptides with Far-Red Emitting Coumarin Fluorophores.

Rovira A, Gandioso A, Goñalons M, Galindo A, Massaguer A, Bosch M, Marchán V.

J Org Chem. 2019 Feb 15;84(4):1808-1817. doi: 10.1021/acs.joc.8b02624. Epub 2019 Jan 25.

PMID:
30628454
7.

Unraveling treatment response in multiple sclerosis: A clinical and MRI challenge.

Gasperini C, Prosperini L, Tintoré M, Sormani MP, Filippi M, Rio J, Palace J, Rocca MA, Ciccarelli O, Barkhof F, Sastre-Garriga J, Vrenken H, Frederiksen JL, Yousry TA, Enzinger C, Rovira A, Kappos L, Pozzilli C, Montalban X, De Stefano N; and the MAGNIMS Study Group.

Neurology. 2019 Jan 22;92(4):180-192. doi: 10.1212/WNL.0000000000006810. Epub 2018 Dec 26. Review.

PMID:
30587516
8.

Fluorescing Isofunctional Ribonucleosides: Assessing Adenosine Deaminase Activity and Inhibition.

Ludford PT, Rovira AR, Fin A, Tor Y.

Chembiochem. 2018 Nov 22. doi: 10.1002/cbic.201800665. [Epub ahead of print]

PMID:
30566279
9.

One-shot domain adaptation in multiple sclerosis lesion segmentation using convolutional neural networks.

Valverde S, Salem M, Cabezas M, Pareto D, Vilanova JC, Ramió-Torrentà L, Rovira À, Salvi J, Oliver A, Lladó X.

Neuroimage Clin. 2018 Dec 10:101638. doi: 10.1016/j.nicl.2018.101638. [Epub ahead of print]

10.

NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival.

Muntasell A, Rojo F, Servitja S, Rubio-Perez C, Cabo M, Tamborero D, Costa-García M, Martínez-Garcia M, Menéndez S, Vazquez I, Lluch A, Gonzalez-Perez A, Rovira A, López-Botet M, Albanell J.

Clin Cancer Res. 2018 Dec 6. doi: 10.1158/1078-0432.CCR-18-2365. [Epub ahead of print]

PMID:
30523021
11.

Standards of Practice in Acute Ischemic Stroke Intervention: International Recommendations.

Pierot L, Jayaraman MV, Szikora I, Hirsch JA, Baxter B, Miyachi S, Mahadevan J, Chong W, Mitchell PJ, Coulthard A, Rowley HA, Sanelli PC, Tampieri D, Brouwer PA, Fiehler J, Kocer N, Vilela P, Rovira A, Fischer U, Caso V, van der Worp B, Sakai N, Matsumaru Y, Yoshimura SI, Anxionnat R, Desal H, Biscoito L, Pumar JM, Diaz O, Fraser JF, Linfante I, Liebeskind DS, Nogueira RG, Hacke W, Brainin M, Yan B, Soderman M, Taylor A, Pongpech S, Tanaka M, Terbrugge K; Asian-Australian Federation of Interventional and Therapeutic Neuroradiology (AAFITN); Australian and New Zealand Society of Neuroradiology (ANZSNR); American Society of Neuroradiology (ASNR); Canadian Society of Neuroradiology (CSNR); European Society of Minimally Invasive Neurological Therapy (ESMINT); European Society of Neuroradiology (ESNR); European Stroke Organization (ESO); Japanese Society for NeuroEndovascular Therapy (JSNET); French Society of Neuroradiology (SFNR); Ibero-Latin American Society of Diagnostic and Therapeutic Neuroradiology (SILAN); Society of NeuroInterventional Surgery (SNIS); Society of Vascular and Interventional Neurology (SVIN); World Stroke Organization (WSO); World Federation of Interventional Neuroradiology (WFITN).

AJNR Am J Neuroradiol. 2018 Nov;39(11):E112-E117. doi: 10.3174/ajnr.A5853. No abstract available.

PMID:
30442688
12.

Standardized assessment of the signal intensity increase on unenhanced T1-weighted images in the brain: the European Gadolinium Retention Evaluation Consortium (GREC) Task Force position statement.

Quattrocchi CC, Ramalho J, van der Molen AJ, Rovira À, Radbruch A; GREC, European Gadolinium Retention Evaluation Consortium and the ESNR, European Society of Neuroradiology.

Eur Radiol. 2018 Nov 9. doi: 10.1007/s00330-018-5803-6. [Epub ahead of print]

PMID:
30413951
13.

Standards of practice in acute ischemic stroke intervention: International recommendations: This article was first published in JNIS. Cite this article as: Pierot L, Jayaraman MV, Szikora I, et al. Standards of practice in acute ischemic stroke intervention: international recommendations. Journal of NeuroInterventional Surgery. Published Online First: 28 August 2018. doi: 10.1136/neurintsurg-2018-014287.

Pierot L, Jayaraman MV, Szikora I, Hirsch JA, Baxter B, Miyachi S, Mahadevan J, Chong W, Mitchell PJ, Coulthard A, Rowley HA, Sanelli PC, Tampieri D, Brouwer PA, Fiehler J, Kocer N, Vilela P, Rovira A, Fischer U, Caso V, van der Worp B, Sakai N, Matsumaru Y, Yoshimura SI, Anxionnat R, Desal H, Biscoito L, Pumar JM, Diaz O, Fraser JF, Linfante I, Liebeskind DS, Nogueira RG, Hacke W, Brainin M, Yan B, Soderman M, Taylor A, Pongpech S, Tanaka M, Karel T; Asian-Australasian Federation of Interventional and Therapeutic Neuroradiology (AAFITN), Australian and New Zealand Society of Neuroradiology (ANZSNR), American Society of Neuroradiology (ASNR), Canadian Society of Neuroradiology (CSNR), European Society of Minimally Invasive Neurological Therapy (ESMINT), European Society of Neuroradiology (ESNR), European Stroke Organization (ESO), Japanese Society for NeuroEndovascular Therapy (JSNET), French Society of Neuroradiology (SFNR), Ibero-Latin American Society of Diagnostic and Therapeutic Neuroradiology (SILAN), Society of NeuroInterventional Surgery (SNIS), Society of Vascular and Interventional Neurology (SVIN), World Stroke Organization (WSO) and World Federation of Interventional and Therapeutic Neuroradiology (WFITN).

Interv Neuroradiol. 2018 Oct 23:1591019918800457. doi: 10.1177/1591019918800457. [Epub ahead of print] No abstract available.

PMID:
30352535
14.

A critical appraisal of the quality of low back pain practice guidelines using the AGREE II tool and comparison with previous evaluations: a EuroAIM initiative.

Doniselli FM, Zanardo M, Manfrè L, Papini GDE, Rovira A, Sardanelli F, Sconfienza LM, Arana E.

Eur Spine J. 2018 Nov;27(11):2781-2790. doi: 10.1007/s00586-018-5763-1. Epub 2018 Sep 15. Review.

PMID:
30220040
15.

Imaging of meningeal inflammation should become part of the routine MRI protocol - Commentary.

Rovira À.

Mult Scler. 2018 Sep 4:1352458518799590. doi: 10.1177/1352458518799590. [Epub ahead of print] No abstract available.

PMID:
30179069
16.

High Photostability in Nonconventional Coumarins with Far-Red/NIR Emission through Azetidinyl Substitution.

Gandioso A, Palau M, Bresolí-Obach R, Galindo A, Rovira A, Bosch M, Nonell S, Marchán V.

J Org Chem. 2018 Oct 5;83(19):11519-11531. doi: 10.1021/acs.joc.8b01422. Epub 2018 Sep 13.

PMID:
30168330
17.

Standards of practice in acute ischemic stroke intervention: international recommendations.

Pierot L, Jayaraman MV, Szikora I, Hirsch JA, Baxter B, Miyachi S, Mahadevan J, Chong W, Mitchell PJ, Coulthard A, Rowley HA, Sanelli PC, Tampieri D, Brouwer PA, Fiehler J, Kocer N, Vilela P, Rovira A, Fischer U, Caso V, van der Worp B, Sakai N, Matsumaru Y, Yoshimura SI, Anxionnat R, Desal H, Biscoito L, Pumar JM, Diaz O, Fraser JF, Linfante I, Liebeskind DS, Nogueira RG, Hacke W, Brainin M, Yan B, Soderman M, Taylor A, Pongpech S, Tanaka M, Karel T; Asian-Australian Federation of Interventional and Therapeutic Neuroradiology (AAFITN), Australianand New Zealand Society of Neuroradiology (ANZSNR), American Society of Neuroradiology (ASNR), Canadian Society of Neuroradiology (CSNR), European Society of Minimally Invasive Neurological Therapy (ESMINT), European Society of Neuroradiology (ESNR), European Stroke Organization (ESO), Japanese Society for NeuroEndovascular Therapy (JSNET), The French Society of Neuroradiology (SFNR) Ibero-Latin American Society of Diagnostic and Therapeutic Neuroradiology (SILAN), Society of NeuroInterventional Surgery (SNIS), Society of Vascular and Interventional Neurology (SVIN), World Stroke Organization (WSO), World Federation of Interventional Neuroradiology (WFITN).

J Neurointerv Surg. 2018 Nov;10(11):1121-1126. doi: 10.1136/neurintsurg-2018-014287. Epub 2018 Aug 28. No abstract available.

PMID:
30154252
18.

Total Synthesis of (-)-Xishacorene B from ( R)-Carvone Using a C-C Activation Strategy.

Kerschgens I, Rovira AR, Sarpong R.

J Am Chem Soc. 2018 Aug 8;140(31):9810-9813. doi: 10.1021/jacs.8b05832. Epub 2018 Jul 25.

PMID:
30032603
19.

Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI.

Amiri H, de Sitter A, Bendfeldt K, Battaglini M, Gandini Wheeler-Kingshott CAM, Calabrese M, Geurts JJG, Rocca MA, Sastre-Garriga J, Enzinger C, de Stefano N, Filippi M, Rovira Á, Barkhof F, Vrenken H; MAGNIMS Study Group.

Neuroimage Clin. 2018 Apr 26;19:466-475. doi: 10.1016/j.nicl.2018.04.023. eCollection 2018. Review.

20.

Progression of regional grey matter atrophy in multiple sclerosis.

Eshaghi A, Marinescu RV, Young AL, Firth NC, Prados F, Jorge Cardoso M, Tur C, De Angelis F, Cawley N, Brownlee WJ, De Stefano N, Laura Stromillo M, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Geurts JJG, Vrenken H, Wottschel V, Leurs CE, Uitdehaag B, Pirpamer L, Enzinger C, Ourselin S, Gandini Wheeler-Kingshott CA, Chard D, Thompson AJ, Barkhof F, Alexander DC, Ciccarelli O.

Brain. 2018 Jun 1;141(6):1665-1677. doi: 10.1093/brain/awy088.

21.

Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging.

Storelli L, Rocca MA, Pagani E, Van Hecke W, Horsfield MA, De Stefano N, Rovira A, Sastre-Garriga J, Palace J, Sima D, Smeets D, Filippi M; MAGNIMS Study Group.

Radiology. 2018 Aug;288(2):554-564. doi: 10.1148/radiol.2018172468. Epub 2018 May 1.

PMID:
29714673
22.

Publisher Correction: MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer.

Gawrzak S, Rinaldi L, Gregorio S, Arenas EJ, Salvador F, Urosevic J, Figueras-Puig C, Rojo F, Del Barco Barrantes I, Cejalvo JM, Palafox M, Guiu M, Berenguer-Llergo A, Symeonidi A, Bellmunt A, Kalafatovic D, Arnal-Estapé A, Fernández E, Müllauer B, Groeneveld R, Slobodnyuk K, Stephan-Otto Attolini C, Saura C, Arribas J, Cortes J, Rovira A, Muñoz M, Lluch A, Serra V, Albanell J, Prat A, Nebreda AR, Benitah SA, Gomis RR.

Nat Cell Biol. 2018 Aug;20(8):990. doi: 10.1038/s41556-018-0052-0.

PMID:
29674681
23.

Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations.

Tamborero D, Rubio-Perez C, Deu-Pons J, Schroeder MP, Vivancos A, Rovira A, Tusquets I, Albanell J, Rodon J, Tabernero J, de Torres C, Dienstmann R, Gonzalez-Perez A, Lopez-Bigas N.

Genome Med. 2018 Mar 28;10(1):25. doi: 10.1186/s13073-018-0531-8.

24.

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N; Jacqueline Palace on behalf of the MAGNIMS study group.

Nat Rev Neurol. 2018 Mar 20;14(4):213. doi: 10.1038/nrneurol.2018.39.

PMID:
29582852
25.

The current role of MRI in differentiating multiple sclerosis from its imaging mimics.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N, Palace J; MAGNIMS study group.

Nat Rev Neurol. 2018 Apr;14(4):199-213. doi: 10.1038/nrneurol.2018.14. Epub 2018 Mar 9. Review. Erratum in: Nat Rev Neurol. 2018 Mar 20;14 (4):213.

PMID:
29521337
26.

The role of the cerebellum in multiple sclerosis-150 years after Charcot.

Parmar K, Stadelmann C, Rocca MA, Langdon D, D'Angelo E, D'Souza M, Burggraaff J, Wegner C, Sastre-Garriga J, Barrantes-Freer A, Dorn J, Uitdehaag BMJ, Montalban X, Wuerfel J, Enzinger C, Rovira A, Tintore M, Filippi M, Kappos L, Sprenger T; MAGNIMS study group.

Neurosci Biobehav Rev. 2018 Jun;89:85-98. doi: 10.1016/j.neubiorev.2018.02.012. Epub 2018 Feb 23. Review.

PMID:
29477616
27.

The value of oligoclonal bands in the multiple sclerosis diagnostic criteria.

Arrambide G, Tintore M, Espejo C, Auger C, Castillo M, Río J, Castilló J, Vidal-Jordana A, Galán I, Nos C, Mitjana R, Mulero P, de Barros A, Rodríguez-Acevedo B, Midaglia L, Sastre-Garriga J, Rovira A, Comabella M, Montalban X.

Brain. 2018 Apr 1;141(4):1075-1084. doi: 10.1093/brain/awy006.

PMID:
29462277
28.

Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations.

De Stefano N, Giorgio A, Tintoré M, Pia Amato M, Kappos L, Palace J, Yousry T, Rocca MA, Ciccarelli O, Enzinger C, Frederiksen J, Filippi M, Vrenken H, Rovira À; MAGNIMS study group.

Mult Scler. 2018 Feb;24(2):214-221. doi: 10.1177/1352458517717808. No abstract available.

PMID:
29451440
29.

The impact factor and RADIOLOGÍA.

Rovira A.

Radiologia. 2018 May - Jun;60(3):181-182. doi: 10.1016/j.rx.2018.01.001. Epub 2018 Feb 9. English, Spanish. No abstract available.

30.

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial.

Montagut C, Argilés G, Ciardiello F, Poulsen TT, Dienstmann R, Kragh M, Kopetz S, Lindsted T, Ding C, Vidal J, Clausell-Tormos J, Siravegna G, Sánchez-Martín FJ, Koefoed K, Pedersen MW, Grandal MM, Dvorkin M, Wyrwicz L, Rovira A, Cubillo A, Salazar R, Desseigne F, Nadal C, Albanell J, Zagonel V, Siena S, Fumi G, Rospo G, Nadler P, Horak ID, Bardelli A, Tabernero J.

JAMA Oncol. 2018 Apr 12;4(4):e175245. doi: 10.1001/jamaoncol.2017.5245. Epub 2018 Apr 12.

31.

Classic Block Design "Pseudo"-Resting-State fMRI Changes After a Neurorehabilitation Program in Patients with Multiple Sclerosis.

Pareto D, Sastre-Garriga J, Alonso J, Galán I, Arévalo MJ, Renom M, Montalban X, Rovira À.

J Neuroimaging. 2018 May;28(3):313-319. doi: 10.1111/jon.12500. Epub 2018 Feb 5.

PMID:
29400912
32.

MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer.

Gawrzak S, Rinaldi L, Gregorio S, Arenas EJ, Salvador F, Urosevic J, Figueras-Puig C, Rojo F, Del Barco Barrantes I, Cejalvo JM, Palafox M, Guiu M, Berenguer-Llergo A, Symeonidi A, Bellmunt A, Kalafatovic D, Arnal-Estapé A, Fernández E, Müllauer B, Groeneveld R, Slobodnyuk K, Stephan-Otto Attolini C, Saura C, Arribas J, Cortes J, Rovira A, Muñoz M, Lluch A, Serra V, Albanell J, Prat A, Nebreda AR, Benitah SA, Gomis RR.

Nat Cell Biol. 2018 Feb;20(2):211-221. doi: 10.1038/s41556-017-0021-z. Epub 2018 Jan 22. Erratum in: Nat Cell Biol. 2018 Apr 19;:.

PMID:
29358704
33.

Circadian Waves of Transcriptional Repression Shape PIF-Regulated Photoperiod-Responsive Growth in Arabidopsis.

Martín G, Rovira A, Veciana N, Soy J, Toledo-Ortiz G, Gommers CMM, Boix M, Henriques R, Minguet EG, Alabadí D, Halliday KJ, Leivar P, Monte E.

Curr Biol. 2018 Jan 22;28(2):311-318.e5. doi: 10.1016/j.cub.2017.12.021. Epub 2018 Jan 11.

34.

Deep gray matter volume loss drives disability worsening in multiple sclerosis.

Eshaghi A, Prados F, Brownlee WJ, Altmann DR, Tur C, Cardoso MJ, De Angelis F, van de Pavert SH, Cawley N, De Stefano N, Stromillo ML, Battaglini M, Ruggieri S, Gasperini C, Filippi M, Rocca MA, Rovira A, Sastre-Garriga J, Vrenken H, Leurs CE, Killestein J, Pirpamer L, Enzinger C, Ourselin S, Wheeler-Kingshott CAMG, Chard D, Thompson AJ, Alexander DC, Barkhof F, Ciccarelli O; MAGNIMS study group.

Ann Neurol. 2018 Feb;83(2):210-222. doi: 10.1002/ana.25145. Epub 2018 Feb 6.

35.

Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study.

Hagens MH, Burggraaff J, Kilsdonk ID, Ruggieri S, Collorone S, Cortese R, Cawley N, Sbardella E, Andelova M, Amann M, Lieb JM, Pantano P, Lissenberg-Witte BI, Killestein J, Oreja-Guevara C, Wuerfel J, Ciccarelli O, Gasperini C, Lukas C, Rovira A, Barkhof F, Wattjes MP; MAGNIMS Study Group.

Mult Scler. 2018 Jan 1:1352458517751647. doi: 10.1177/1352458517751647. [Epub ahead of print]

PMID:
29327668
36.

Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab.

Hardy-Werbin M, Arpí O, Taus A, Rocha P, Joseph-Pietras D, Nolan L, Danson S, Griffiths R, Lopez-Botet M, Rovira A, Albanell J, Ottensmeier CH, Arriola E.

Oncoimmunology. 2017 Nov 27;7(2):e1395125. doi: 10.1080/2162402X.2017.1395125. eCollection 2018.

37.

Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis.

Aymerich FX, Auger C, Alonso J, Alberich M, Sastre-Garriga J, Tintoré M, Montalban X, Rovira A.

AJNR Am J Neuroradiol. 2018 Feb;39(2):399-404. doi: 10.3174/ajnr.A5495. Epub 2017 Dec 28.

38.

Redesigning the Coumarin Scaffold into Small Bright Fluorophores with Far-Red to Near-Infrared Emission and Large Stokes Shifts Useful for Cell Imaging.

Gandioso A, Bresolí-Obach R, Nin-Hill A, Bosch M, Palau M, Galindo A, Contreras S, Rovira A, Rovira C, Nonell S, Marchán V.

J Org Chem. 2018 Feb 2;83(3):1185-1195. doi: 10.1021/acs.joc.7b02660. Epub 2018 Jan 11.

PMID:
29283264
39.

Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.

Filippi M, Preziosa P, Meani A, Ciccarelli O, Mesaros S, Rovira A, Frederiksen J, Enzinger C, Barkhof F, Gasperini C, Brownlee W, Drulovic J, Montalban X, Cramer SP, Pichler A, Hagens M, Ruggieri S, Martinelli V, Miszkiel K, Tintorè M, Comi G, Dekker I, Uitdehaag B, Dujmovic-Basuroski I, Rocca MA.

Lancet Neurol. 2018 Feb;17(2):133-142. doi: 10.1016/S1474-4422(17)30469-6. Epub 2017 Dec 21.

PMID:
29275979
40.

A supervised framework with intensity subtraction and deformation field features for the detection of new T2-w lesions in multiple sclerosis.

Salem M, Cabezas M, Valverde S, Pareto D, Oliver A, Salvi J, Rovira À, Lladó X.

Neuroimage Clin. 2017 Nov 20;17:607-615. doi: 10.1016/j.nicl.2017.11.015. eCollection 2018.

41.

Emissive Synthetic Cofactors: Enzymatic Interconversions of tz A Analogues of ATP, NAD+ , NADH, NADP+ , and NADPH.

Hallé F, Fin A, Rovira AR, Tor Y.

Angew Chem Int Ed Engl. 2018 Jan 22;57(4):1087-1090. doi: 10.1002/anie.201711935. Epub 2017 Dec 21.

42.

Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy.

Muntasell A, Cabo M, Servitja S, Tusquets I, Martínez-García M, Rovira A, Rojo F, Albanell J, López-Botet M.

Front Immunol. 2017 Nov 13;8:1544. doi: 10.3389/fimmu.2017.01544. eCollection 2017. Review.

43.

Chelated or dechelated gadolinium deposition.

Radbruch A, Roberts DR, Clement O, Rovira A, Quattrocchi CC.

Lancet Neurol. 2017 Dec;16(12):955. doi: 10.1016/S1474-4422(17)30364-2. Epub 2017 Nov 14. No abstract available.

PMID:
29165253
44.

Evaluation of microplastic release caused by textile washing processes of synthetic fabrics.

De Falco F, Gullo MP, Gentile G, Di Pace E, Cocca M, Gelabert L, Brouta-Agnésa M, Rovira A, Escudero R, Villalba R, Mossotti R, Montarsolo A, Gavignano S, Tonin C, Avella M.

Environ Pollut. 2018 May;236:916-925. doi: 10.1016/j.envpol.2017.10.057. Epub 2017 Oct 27.

PMID:
29107418
45.

Lesion topographies in multiple sclerosis diagnosis: A reappraisal.

Arrambide G, Tintore M, Auger C, Río J, Castilló J, Vidal-Jordana A, Galán I, Nos C, Comabella M, Mitjana R, Mulero P, de Barros A, Rodríguez-Acevedo B, Midaglia L, Sastre-Garriga J, Rovira A, Montalban X.

Neurology. 2017 Dec 5;89(23):2351-2356. doi: 10.1212/WNL.0000000000004715. Epub 2017 Nov 3.

46.

Importance of neoadjuvant chemotherapy in olfactory neuroblastoma treatment: Series report and literature review.

Bartel R, Gonzalez-Compta X, Cisa E, Cruellas F, Torres A, Rovira A, Manos M.

Acta Otorrinolaringol Esp. 2018 Jul - Aug;69(4):208-213. doi: 10.1016/j.otorri.2017.07.001. Epub 2017 Oct 20. English, Spanish.

47.

Machine learning applied to neuroimaging for diagnosis of adult classic Chiari malformation: role of the basion as a key morphometric indicator.

Urbizu A, Martin BA, Moncho D, Rovira A, Poca MA, Sahuquillo J, Macaya A, Español MI.

J Neurosurg. 2018 Sep;129(3):779-791. doi: 10.3171/2017.3.JNS162479. Epub 2017 Oct 20.

PMID:
29053075
48.

Emissive Synthetic Cofactors: An Isomorphic, Isofunctional, and Responsive NAD+ Analogue.

Rovira AR, Fin A, Tor Y.

J Am Chem Soc. 2017 Nov 8;139(44):15556-15559. doi: 10.1021/jacs.7b05852. Epub 2017 Oct 27.

49.

Performance of five research-domain automated WM lesion segmentation methods in a multi-center MS study.

de Sitter A, Steenwijk MD, Ruet A, Versteeg A, Liu Y, van Schijndel RA, Pouwels PJW, Kilsdonk ID, Cover KS, van Dijk BW, Ropele S, Rocca MA, Yiannakas M, Wattjes MP, Damangir S, Frisoni GB, Sastre-Garriga J, Rovira A, Enzinger C, Filippi M, Frederiksen J, Ciccarelli O, Kappos L, Barkhof F, Vrenken H; MAGNIMS study group and for neuGRID.

Neuroimage. 2017 Dec;163:106-114. doi: 10.1016/j.neuroimage.2017.09.011. Epub 2017 Sep 9.

PMID:
28899746
50.

Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer.

Sabbaghi M, Gil-Gómez G, Guardia C, Servitja S, Arpí O, García-Alonso S, Menendez S, Arumi-Uria M, Serrano L, Salido M, Muntasell A, Martínez-García M, Zazo S, Chamizo C, González-Alonso P, Madoz-Gúrpide J, Eroles P, Arribas J, Tusquets I, Lluch A, Pandiella A, Rojo F, Rovira A, Albanell J.

Clin Cancer Res. 2017 Nov 15;23(22):7006-7019. doi: 10.1158/1078-0432.CCR-17-0696. Epub 2017 Aug 18.

Supplemental Content

Loading ...
Support Center